Statement of Cash Flows (Tables)

3 Months Ended

Mar. 31, 2024

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:

	March 31,
(In millions)	2024		2023
Cash and cash equivalents	$	2,602.0	$	3,916.3
Restricted cash included in Other noncurrent assets	7.8		12.5
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$	2,609.8	$	3,928.8

Restrictions on Cash and Cash Equivalents

The following provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same such amounts shown in the Condensed Consolidated Statements of Cash Flows:

	March 31,
(In millions)	2024		2023
Cash and cash equivalents	$	2,602.0	$	3,916.3
Restricted cash included in Other noncurrent assets	7.8		12.5
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	$	2,609.8	$	3,928.8

Summary of Non-Cash Investing and Financing Activities

	March 31,		December 31,		March 31,		December 31,
(In millions)	2024		2023		2023		2022
Accrued capital expenditures	$	108.0	$	75.4	$	90.3	$	70.8
Accrued contingent consideration in connection with acquisitions	$	88.8	$	71.6	$	55.2	$	135.5